GNL Gut and Liver
  1. Wei-Kei Wong, Wah-Kheong Chan. Nonalcoholic Fatty Liver Disease: A Global Perspective. Clinical Therapeutics 2021;43:473
    https://doi.org/10.1016/j.clinthera.2021.01.007
  2. Noriyo Urata, Miwa Kawanaka, Ken Nishino, Katsunori Ishii, Tomohiro Tanikawa, Mitsuhiko Suehiro, Takako Sasai, Ken Haruma, Hirofumi Kawamoto, Jun Nakamura, Noriaki Manabe, Tomoari Kamada. Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study. Life 2020;10:175
    https://doi.org/10.3390/life10090175
  3. Yuko Nagaoki, Hideyuki Hyogo, Yuwa Ando, Yumi Kosaka, Shinsuke Uchikawa, Yuno Nishida, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Wataru Okamoto, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Daiki Miki, Michio Imamura, Shoichi Takahashi, Kazuaki Chayama, Hiroshi Aikata. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study. BMC Gastroenterol 2021;21
    https://doi.org/10.1186/s12876-021-01884-5
  4. Jingjing Han, Hyo Won Lee, Yahui Chen, Haidong Li, Hwan Myung Kim, Juyoung Yoon. Observing hepatic steatosis with a commercially viable two-photon fluorogenic probe. Mater. Chem. Front. 2022;6:553
    https://doi.org/10.1039/D1QM01665B
  5. Jessica Musto, Erin K. Spengler, Margarita N. German. Sexual Dimorphisms in Nonalcoholic Fatty Liver Disease. Curr Hepatology Rep 2021;20:97
    https://doi.org/10.1007/s11901-021-00568-8
  6. Zhiyong He, Yangyang Bin, Guangshun Chen, Qiang Li, Wenling Fan, Yongqiang Ma, Junfang Yi, Xiaohua Luo, Zhi Tan, Jiequn Li. Identification of MAP3K4 as a novel regulation factor of hepatic lipid metabolism in non-alcoholic fatty liver disease. J Transl Med 2022;20
    https://doi.org/10.1186/s12967-022-03734-8
  7. Runzhi Yu, Yiqin Huang, Xiaona Hu, Jie Chen. Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis. Heliyon 2024;10:e32783
    https://doi.org/10.1016/j.heliyon.2024.e32783
  8. Patrizia Burra, Debora Bizzaro, Anna Gonta, Sarah Shalaby, Martina Gambato, Maria Cristina Morelli, Silvia Trapani, Annarosa Floreani, Fabio Marra, Maurizia Rossana Brunetto, Gloria Taliani, Erica Villa. Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH). Liver International 2021;41:1713
    https://doi.org/10.1111/liv.14943
  9. Takumi Noda, Kentaro Kamiya, Nobuaki Hamazaki, Kohei Nozaki, Takafumi Ichikawa, Masashi Yamashita, Shota Uchida, Emi Maekawa, Tasuku Terada, Jennifer L. Reed, Minako Yamaoka-Tojo, Atsuhiko Matsunaga, Junya Ako. The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome. JCM 2022;11:1847
    https://doi.org/10.3390/jcm11071847
  10. Miwa Kawanaka, Ken Nishino, Mayuko Kawada, Katsunori Ishii, Tomohiro Tanikawa, Ryo Katsumata, Noriyo Urata, Jun Nakamura, Mitsuhiko Suehiro, Ken Haruma, Hirofumi Kawamoto. Lean nonalcoholic fatty liver disease: Age‐dependent differences in pathology, prognosis, and liver‐related events. Hepatology Research 2023;53:829
    https://doi.org/10.1111/hepr.13911
  11. Kei Tokutsu, Kaoru Ito, Shigeki Kawazoe, Sota Minami, Kenji Fujimoto, Keiji Muramatsu, Shinya Matsuda. Clinical characteristics in patients with non-alcoholic steatohepatitis in Japan: a case–control study using a 5-year large-scale claims database. BMJ Open 2023;13:e074851
    https://doi.org/10.1136/bmjopen-2023-074851
  12. Tomomi Kogiso, Etsuko Hashimoto. Are low triglyceride levels the cause or an outcome of advanced liver fibrosis in elderly patients with nonalcoholic fatty liver disease?. J of Gastro and Hepatol 2020;35:1459
    https://doi.org/10.1111/jgh.15226
  13. Zhe Guo, Glen M. Blake, Peter M. Graffy, Veit Sandfort, Ronald M. Summers, Kai Li, Shaoqi Xu, Yizhong Chen, Jun Zhou, Jiman Shao, Yonghong Jiang, Haibo Qu, Baoqing Li, Xiaoguang Cheng, Perry J. Pickhardt. Hepatic Steatosis: CT-Based Prevalence in Adults in China and the United States and Associations With Age, Sex, and Body Mass Index. American Journal of Roentgenology 2022;218:846
    https://doi.org/10.2214/AJR.21.26728
  14. Ali Junaid Dar, Akash John, Abid Ali, Arooj Ansar, Sheza Azam. Chronic Liver Disease: Liver Cirrhosis and Diagnostic Features. PJHS 2023:30
    https://doi.org/10.54393/pjhs.v4i01.511
  15. Shuji Terai, Amy Buchanan-Hughes, Alvin Ng, I-Heng Lee, Ken Hasegawa. Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database. J Gastroenterol 2021;56:274
    https://doi.org/10.1007/s00535-021-01759-2
  16. Fatma Al Ghaithi, Mostafa I. Waly, Yahya Al-Farsi, Zainab Al Mukhaini, Ruqaiya Al Balushi, Ahmed Almashrafi. Biochemical and nutritional determinants of non-alcoholic fatty liver disease in Omani adult patients: a case-control study. 2024;14:407
    https://doi.org/10.4103/ijnpnd.ijnpnd_57_24
  17. Xinxin Zhang, Jinfeng Xiao, Qi Liu, Yuanyuan Ye, Weihong Guo, Jingqiu Cui, Qing He, Wenli Feng, Ming Liu, Ma Gorzata Kotula Balak. Low Serum Total Testosterone Is Associated with Non-Alcoholic Fatty Liver Disease in Men but Not in Women with Type 2 Diabetes Mellitus. International Journal of Endocrinology 2022;2022:1
    https://doi.org/10.1155/2022/8509204
  18. Motoyuki Otsuka. Current status and problems regarding HCC screening for the NAFLD patients. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 2023;135:18
    https://doi.org/10.4044/joma.135.18
  19. I. A. Bulatova, T. P. Shevlyukova. Features of the course of non-alcoholic fatty liver disease in women at different age periods: literature review. Medicinskij sovet 2024:90
    https://doi.org/10.21518/ms2024-112
  20. Yuko Nagaoki, Aya Sugiyama, Megumi Mino, Hiroomi Kodama, Kanon Abe, Hirohito Imada, Serge Ouoba, Bunthen E, Ko Ko, Tomoyuki Akita, Toru Sako, Takashi Kumada, Kazuaki Chayama, Junko Tanaka. Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample. Hepatology Research 2022;52:908
    https://doi.org/10.1111/hepr.13821
  21. Erdenetsogt Dungubat, Hiroyuki Kusano, Ichiro Mori, Hirosuke Tawara, Mitsuko Sutoh, Naoki Ohkura, Masakatsu Takanashi, Masahiko Kuroda, Naoki Harada, Emiko Udo, Masakazu Souda, Bungo Furusato, Toshio Fukusato, Yoshihisa Takahashi, Nobuyuki Takahashi. Age-dependent sex difference of non-alcoholic fatty liver disease in TSOD and db/db mice. PLoS ONE 2022;17:e0278580
    https://doi.org/10.1371/journal.pone.0278580
  22. Yasuhiro Matsubayashi, Kazuya Fujihara, Mayuko Yamada-Harada, Yurie Mitsuma, Takaaki Sato, Yuta Yaguchi, Taeko Osawa, Masahiko Yamamoto, Masaru Kitazawa, Takaho Yamada, Satoru Kodama, Hirohito Sone. Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex. Cardiovasc Diabetol 2022;21
    https://doi.org/10.1186/s12933-022-01518-4
  23. Amedeo Lonardo, Ayako Suzuki. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research. JCM 2020;9:1278
    https://doi.org/10.3390/jcm9051278
  24. Feng Hong, Yubo Liu, Veeranjaneya Reddy Lebaka, Arifullah Mohammed, Weibing Ye, Biqing Chen, Mallikarjuna Korivi. Effect of Exercise Training on Serum Transaminases in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Front. Physiol. 2022;13
    https://doi.org/10.3389/fphys.2022.894044
  25. Sitara Niranjan, Brett E. Phillips, Nick Giannoukakis. Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes. Front. Endocrinol. 2023;14
    https://doi.org/10.3389/fendo.2023.1193373
  26. Noel C. Salvoza, Pablo J. Giraudi, Claudio Tiribelli, Natalia Rosso. Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease. 2020;1:51
    https://doi.org/10.37349/emed.2020.00005
  27. Sung Hoon Kang, Heejin Yoo, Bo Kyoung Cheon, Jun Pyo Kim, Hyemin Jang, Hee Jin Kim, Mira Kang, Kyungmi Oh, Seong-Beom Koh, Duk L. Na, Yoosoo Chang, Sang Won Seo. Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals. Front. Aging Neurosci. 2023;15
    https://doi.org/10.3389/fnagi.2023.1277392
  28. Dong-Hyuk Jung, Yong Jae Lee, Byoungjin Park. Joint Effect of Hepatic Steatosis and Alanine Aminotransferase Within the Normal Range on Incident Ischemic Heart Disease: A Prospective Study in Koreans. CIA 2021;Volume 16:513
    https://doi.org/10.2147/CIA.S301741
  29. Shanmugam Murugaiha Jeyakumar, Ayyalasomayajula Vajreswari. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence. WJH 2022;14:168
    https://doi.org/10.4254/wjh.v14.i1.168
  30. Ying Shi, Lin Wei, Lin Xing, Shanyu Wu, Fangzhi Yue, Ke Xia, Dongmei Zhang. Sex Difference is a Determinant of Gut Microbes and Their Metabolites SCFAs/MCFAs in High Fat Diet Fed Rats. Curr Microbiol 2022;79
    https://doi.org/10.1007/s00284-022-03025-x
  31. Catherine Li, Timothy J. Chalmers, Ashley S.A. Wong, Moran Zhou, Maria B. Marinova, Michael J. Bertoldo, Lindsay E. Wu. The Stem Cell Niche during Ageing. 2022.
    https://doi.org/10.1016/bs.asn.2020.07.002
  32. Hyeong Ho Jo, Nayoung Kim, Jieun Jang, Yonghoon Choi, Jaehyung Park, Young Mi Park, Soyeon Ahn, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hyeon Jeong Oh, Hye Seung Lee, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim. Impact of Body Mass Index on Survival Depending on Sex in 14,688 Patients with Gastric Cancer in a Tertiary Hospital in South Korea. Gut and Liver 2023;17:243
    https://doi.org/10.5009/gnl220104
  33. Kosuke Ushiro, Akira Fukuda, Masahiro Matsui, Saori Onishi, Tomohiro Nishikawa, Akira Asai, Soo Ki Kim, Hiroki Nishikawa. Body Composition in Cases with Normal Alanine Aminotransferase Values in Medical Health Checkups. Nutrients 2024;16:3847
    https://doi.org/10.3390/nu16223847
  34. Xiaomei Zhang, Shi Wang, Sanping Xu, Rui Min, Yan Ling, Shiran Sun, Rui Gong. Clinical Characteristics, Risk Factors, and Predictors of Nonobese Fatty Liver Disease: A Cross-Sectional Study. DMSO 2024;Volume 17:4397
    https://doi.org/10.2147/DMSO.S482638
  35. Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?. WJH 2022;14:304
    https://doi.org/10.4254/wjh.v14.i2.304
  36. Feng‐Bin Lu, Kenneth I Zheng, Rafael S Rios, Giovanni Targher, Christopher D Byrne, Ming‐Hua Zheng. Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis. J of Gastro and Hepatol 2020;35:2041
    https://doi.org/10.1111/jgh.15156
  37. Miwa Tatsuta, Masafumi Ono, Shungo Kimura, Kaori Zuigyo, Yudai Sato, Akemi Tomida, Mitsuyoshi Kobayashi, Ritsuko Yoshikawa, Satoshi Murao, Joji Tani, Asahiro Morishita, Hideki Kobara, Takashi Himoto, Tsuyoshi Maeta, Yoshihiro Mori, Fumikazu Kohi, Tsutomu Masaki. HbA1c of 5.8% or higher as the most useful indicator for recommendation of ultrasonography to detect nonalcoholic fatty liver disease. JGH Open 2023;7:990
    https://doi.org/10.1002/jgh3.13019
  38. Shouling Wu, Yuhao Li, Yijun Zhang, Xin Su, Yingting Zuo, Guojuan Chen, Guozheng Xu, Shuohua Chen, Yan He, Anxin Wang. Sex and Age Differences in the Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Heart Failure: A Prospective Cohort Study. Circ: Heart Failure 2024;17
    https://doi.org/10.1161/CIRCHEARTFAILURE.123.010841
  39. Maki Tobari, Etsuko Hashimoto, Makiko Taniai, Takayoshi Nishino, Katsutoshi Tokushige. Hepatocellular carcinoma in young morbid obese patients with non-alcoholic fatty liver disease. Clin J Gastroenterol 2020;13:1289
    https://doi.org/10.1007/s12328-020-01215-3
  40. Amedeo Lonardo, Stefano Ballestri. Perspectives of nonalcoholic fatty liver disease research: a personal point of view. 2020;1:85
    https://doi.org/10.37349/emed.2020.00007
  41. Takahiro Nagata, Sadahiro Funakoshi, Daisuke Morihara, Satoshi Shakado, Keiji Yokoyama, Kazuhide Takata, Takashi Tanaka, Atsushi Fukunaga, Ryo Yamauchi, Hiromi Fukuda, Hiroki Matsuoka, So Imakiire, Hideto Sakisaka, Satoshi Matsuoka, Nobuaki Kuno, Koichi Abe, Hideki Ishibashi, Shinya Ashizuka, Fumihito Hirai. Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study. Intest Res 2023;21:471
    https://doi.org/10.5217/ir.2023.00035
  42. Xiaojie He, Xinyue Huang, Yafang Qian, Ting Sun. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis. Front. Endocrinol. 2023;14
    https://doi.org/10.3389/fendo.2023.1188214
  43. Chao Wang, Xin Huang, Shiming He, Maobin Kuang, Guobo Xie, Guotai Sheng, Yang Zou. The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective. Lipids Health Dis 2024;23
    https://doi.org/10.1186/s12944-024-02299-3
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd